Visco, Carlo <br/><br/>
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.  [electronic resource] 

 -  Blood  11 2019 
 - 1708-1711 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood.2019001617  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Benzoates--adverse effects<br/>Blood Platelets--drug effects<br/>Chronic Disease<br/>Female<br/>Humans<br/>Hydrazines--adverse effects<br/>Lymphoproliferative Disorders--complications<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Purpura, Thrombocytopenic, Idiopathic--complications<br/>Pyrazoles--adverse effects